The endobronchial valve is a one-way valve that is used in patients with chronic obstructive pulmonary disease (COPD). The endobronchial valve enables a unidirectional flow of air into the airways and thereby reduces shortness of breath in the case of lung diseases or emphysema. Emphysema is a precise type of the chronic obstructive pulmonary disease in which the alveoli are damaged. It is a form of chronic lung disease that causes shortness of breath.
Emphysema is
also known as obstructive disorder, where the flow of air or exhalation slows
or stops due to excessive inflammation of the alveoli. To treat emphysema, the
endobronal valve closes during inhalation, preventing air from entering the
damaged part of the lung. However, these valves open during the exhalation,
letting out trapped air, which is proposed to reduce the pressure. The
increasing popularity of the bronchoscopic lung volume reduction method for
numerous lung-related diseases will bring immense growth prospects to the
market for endobronchial valves during the evaluation period.
As per
analysis, “Endobronchial Valve System Market: Current Analysis
and Forecast (2021-2027)” the key companies operating in the
global endobronchial valve system market include Novatech, Spiration Inc., Olympus
Corporation, Pulmonx Corporation (ZEPHYR), Medlung and among others. Strategic
partnerships are essential for the growth of the endobronchial valves market. Leading
players are involved in these definite collaborations to reinforce their
influence on the global endobronchial valve market.
Research
& development activities constitute an important part of the endobronchial
valve market. The players in the endobronchial valve market are investing
heavily in these businesses. The activities help to formulate new business
strategies and also lead to the emergence of new formulations which help to
broaden the growth base of the Endobronchial Valves market. All of these
factors translate into increased revenue, ultimately helping to lay a solid
foundation for the growth of the Endobronchial Valves market.
Major factor
estimated to drive the growth of the endobronchial valve market is the
increasing awareness of the bronchoscopic lung volume reduction procedure in
various lung diseases. Consequently, rise in prevalence of smoking is likely to
contribute the growth of the endobronchial valve market. Chronic obstructive
pulmonary disease (COPD) is one of the main lung disorders. With the growth of
the geriatric population, which is more often susceptible to lung disease, the
demand for endobronchial valve is expected to increase at a linear rate.
Based on
regional analysis, the North-America is a leading region in global endobronchial
valve system market owing to rise in prevalence of chronic obstructive
pulmonary disease across the region. The Europe and Asia-Pacific regions are
estimated to witness higher growth rate growth in geriatric population over the
forecast period. It is projected that future of the global endobronchial valve
system market will be bright as a result of rise in awareness regarding the
procedure for bronchoscopic lung volume reduction in a variety of lung-related
diseases.
For More Information, refer to
below link:-
Global
Endobronchial Valve System Market
Contact
Us:-
Ken
Research
Ankur Gupta, Head Marketing & Communications
Support@kenresearch.com
+91-9015378249
